about
Interventions for female drug-using offendersPharmacological interventions for drug-using offendersInterventions for female drug-using offendersPharmacological interventions for drug-using offendersOral naltrexone maintenance treatment for opioid dependenceOral naltrexone maintenance treatment for opioid dependenceMaintenance treatments for opiate dependent adolescentSimilarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivityCurrent and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.Pharmacological enhancement of naltrexone treatment for opioid dependence: a reviewPatterns of nicotinic receptor antagonism: nicotine discrimination studies.Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid DependenceEffect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patientsDepot naltrexone decreases rewarding properties of sugar in patients with opioid dependenceDesign of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review.Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research.Naltrexone extended-release injection: an option for the management of opioid abuse.Naltrexone depot formulations for opioid and alcohol dependence: a systematic review.Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.Medications for substance use disorders.Long-acting Preparations in Substance Abuse Management: A Review and Update.A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence.Excess mortality among opioid-using patients treated with oral naltrexone in Australia.Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.Is sustained release natrexone an option for heroin-dependent pregnant women?Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.
P2860
Q24187327-543F3B54-07AB-4D46-A3F8-16521AD12147Q24187352-D3EA76B6-BCFC-4F0E-895F-3FD84858D178Q24201193-11E2562A-A494-4DB0-B2DC-F4423624ECA4Q24201693-79AAAD52-02A6-4047-8490-E03B227B9004Q24235092-3F343F38-B4CD-40B0-BC10-85F6B1317789Q24236708-028AD2C8-B63F-445B-ABDD-2175E0966AE8Q24241116-BE74929D-6A57-4E45-9824-5267C461DD6AQ24616099-338D5EF2-60BF-4FC0-BD55-16BADA64828BQ27692554-181088DE-FAFF-4FD9-8504-92CBEB02C42BQ30751889-B7620BD5-24C9-48F3-8BD0-BFEAF1976103Q33582025-604075D7-8AE7-43D5-B28F-9AB2E19AEBC5Q35084340-A060BA5D-D2B3-49AB-BC50-EC176FF971ACQ35265699-A5DC7183-DC97-422B-B2B3-6779FF7599C7Q35670689-4205E548-AB0C-45D6-87B8-414549504263Q35695148-0C3982BE-DE20-4BE0-A98B-63A892CBA1A3Q35751878-1689E866-DF9B-4E64-9CBB-A51FE0EEFF13Q35781879-008216DE-B761-47BA-A803-439D425A95D9Q35827908-2D7B16C2-E122-4452-9934-5D59079F4B4DQ36001217-1EA2E1AE-C78C-4A3E-B906-0F18A4B9BDB6Q36542707-AFA059FB-58FA-4844-B37E-58E0C0847B09Q36734579-5FBDD474-FA1E-41EA-ABA8-5F836D2298C8Q37146962-F792813C-2EB5-4614-8ADC-84997F8D8D2EQ37355293-B57461AF-20AE-4788-BE2A-DE57325A9BE4Q37873579-39648B37-9C9C-4103-A088-065372D10321Q37999447-9C08660C-2477-4621-881C-90596B9FFE7BQ38111473-519C2B47-7179-497F-8549-F2B59325608EQ38119942-681E8557-E810-48DB-B0A2-380739980379Q38168314-86BDBA51-018E-4EA4-8F61-EF46EEE8F0ECQ38258810-DA282C35-3FA7-45D5-BC14-C2ED5A8A4A90Q40112906-446F4C5B-3BC9-40F6-9CEE-CB4337D5C714Q43117967-64634DED-2425-40F0-987B-26379615B713Q43503477-68C1096E-8118-44A1-8329-8AA1015F58BBQ44351026-05EEE603-9E0A-45DF-9B77-03BEFB463D2BQ48210688-B0AC8272-2FDE-486F-9CBA-3C3F6DAF3580
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Sustained-Release Naltrexone For Opioid Dependence
@ast
Sustained-Release Naltrexone For Opioid Dependence
@en
Sustained-Release Naltrexone For Opioid Dependence
@en-gb
Sustained-Release Naltrexone For Opioid Dependence
@nl
type
label
Sustained-Release Naltrexone For Opioid Dependence
@ast
Sustained-Release Naltrexone For Opioid Dependence
@en
Sustained-Release Naltrexone For Opioid Dependence
@en-gb
Sustained-Release Naltrexone For Opioid Dependence
@nl
prefLabel
Sustained-Release Naltrexone For Opioid Dependence
@ast
Sustained-Release Naltrexone For Opioid Dependence
@en
Sustained-Release Naltrexone For Opioid Dependence
@en-gb
Sustained-Release Naltrexone For Opioid Dependence
@nl
P2093
P2860
P3181
P1476
Sustained-Release Naltrexone For Opioid Dependence
@en
P2093
Hege Kornor
Nikolaj Kunoe
Philipp Lobmaier
P2860
P3181
P356
10.1002/14651858.CD006140.PUB2
P577
2008-04-23T00:00:00Z